After nearly four years, first serving as Chairman of the Board and soon after becoming the CEO of Elos Medtech, Stefano Alfonsi will be stepping down from his position as CEO for personal reasons by the 1st of November 2025. Stefano will remain a member of the Board of Directors.
Stefano has shaped Elos’ strategy, strengthened the commercial and customer focus, significantly expanded our global capabilities with the Klingel Acquisition and has taken Elos private. We appreciate Stefano’s ambitious leadership and his steadfast commitment to reimagining partnerships to enhance lives.
Looking forward, we are pleased to share that Winfried Schaller, who has served on our Board of Directors for the past two and a half years, will assume the role of CEO. Having collaborated closely with our senior leadership, Winfried possesses keen insight into our business, is strongly aligned with our values and shares our dedication to a customer first approach and our growth and innovation journey ahead.
Winfried is an outstanding leader with more than 30 years of international leadership experience. His proven track record of transforming and globalizing businesses across multiple industries makes him ideally suited to guide Elos. His deep expertise in strategy, operational transformation, and M&A will be instrumental in leading Elos into its next phase of growth and innovation.
To all employees, customers, and partners — thank you for your ongoing trust. We remain committed to delivering exceptional value through innovation, partnership, and aiming for excellence in everything we do.